Principal Research Scientist
Amy Siu, M.S., Scientist, Eisai Inc.
Amy Siu is currently a Scientist at Eisai Inc. in Andover, MA. She has been the Head of the Drug Metabolism Group since 2012. Prior to this, she was a principal scientist in the DMPK of Infectious Disease CEDD at GlaxoSmithKline Inc. in Research Triangle Park, North Carolina. She received her master’s degree in Nutritional Biochemistry from the University of North Carolina at Chapel. She currently chairs the SLAS ADMET Special Interest Group and participates in the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Working Group for Drug Metabolizing Enzyme Induction. Through her work conducted at GlaxoSmithKline, Amy Siu holds a patent entitled “Methods for detecting LP-PLA2 activity and inhibition of LP-PLA2 activity”. She is a member of the International Society for the Study of Xenobiotics.
Tuesday, January 28, 2020
8:00 AM – 9:15 AM